JR
Highly rated in
5
conditions
Highly rated in
5
conditions
Check Dr. James K. Richardson's experience treating your condition:
About Dr. James K. Richardson

James Richardson is a Physiatrist and a Neuroradiologist in Ann Arbor, Michigan. Richardson has been practicing medicine for over 38 years and is highly rated in 5 conditions, according to our data. His top areas of expertise are Sensorimotor Polyneuropathy, Distal Median Nerve Dysfunction, Foot Drop, and Common Peroneal Nerve Dysfunction. He is licensed to treat patients in Michigan. Richardson is currently accepting new patients.

His clinical research consists of co-authoring 59 peer reviewed articles in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. James K. Richardson it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. James K. Richardson accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Molina Healthcare
  •  Meridian
  •  McLaren Health

Call to see if your plan is accepted.
Locations
1500 E Medical Center Dr, Ann Arbor, MI 48109
Other Locations
1500 E Medical Center Dr, Ann Arbor, MI 48109
325 E Eisenhower Pkwy, Ann Arbor, MI 48108
Background & Education
Graduate Institution
University Of Cincinnati College Of Medicine, 1984.0
Specialties
Physiatry
Neuroradiology
Licenses
Electrodiagnostic Medicine in MI
Hospital Affiliations
University Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


59 Total Publications

Chemotherapy-induced peripheral neuropathy onset is associated with early risk of depression and anxiety in breast cancer survivors.
Summary: Chemotherapy-induced peripheral neuropathy onset is associated with early risk of depression and anxiety in breast cancer survivors.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors